Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

Contact
Request a demo
Request data updates
Add a company

Research

Companies
Investors
People

aVenture

Sitemap
Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage

Loading

Loading

Norbert Bischofberger

AddedMar 31, 2024

UpdatedJun 28, 2026

Norbert Bischofberger

Norbert Bischofberger

Board Member, Bayer

Crunchbase LinkedIn

Norbert Bischofberger's Career

Bayer

Leverkusen, North Rhine-Westphalia, DE

Board Member· Board

Kronos Bio

San Mateo, CA, US

Board Member· Board

Morphic Therapeutic

Morphic Therapeutic

Waltham, MA, US

Board Member· Board

Rezo Therapeutics

Rezo Therapeutics

South San Francisco, CA, US

Board Member· Board

InCarda Therapeutics

InCarda Therapeutics

Newark, CA, US

Board Member· Board

Create your profile now and gain access to exclusive deals and high-potential startups.

aVenture product preview

aVenture product preview

aVenture product preview

Norbert Bischofberger's Career

Bayer

Public$3B101.4k1863Leverkusen, North Rhine-Westphalia, DE

Board Member· Board

Recent news

Fermata uses computer vision to detect diseases and pests in plantsTechCrunch · 2025

Leadership at Bayer

Bill AndersonBoard Member

Rodrigo SantosBoard Member

Stefan OelrichBoard Member

Paul AchleitnerBoard Member

Wolfgang NicklBoard Member

Werner BaumannBoard Member

Similar to Bayer

Bayer PharmaceuticalsBerlin, Berlin, DEDrugs, Pharmaceuticalsest. 2003Bayer PharmaceuticalsBerlin, Berlin, DE · est. 2003

Bayer Pharmaceuticals: A global enterprise specializing in biochemical research and drug manufacturing since 2008.

Boehringer IngelheimIngelheim am Rhein, Rhineland-Palatinate, DEPharmaceuticals, Veterinaryest. 1885Boehringer IngelheimIngelheim am Rhein, Rhineland-Palatinate, DE · est. 1885

German-based Boehringer Ingelheim GmbH innovates, manufactures, and markets high-value pharmaceuticals for humans and animals.

Merck & CO INC Cedear EAC 5 RERahway, NJ, USPharmaceuticalsest. 1891Merck & CO INC Cedear EAC 5 RERahway, NJ, US · est. 1891

Global healthcare company in Rahway, NJ, offering pharmaceutical and animal health products and solutions.

Public · $8.2M69k

BASFLudwigshafen, Rhineland-Palatinate, DEChemicals, Plasticsest. 1865BASFLudwigshafen, Rhineland-Palatinate, DE · est. 1865

BASF is a German chemical company that produces chemicals, materials, and agricultural solutions for industrial customers worldwide.

Kronos Bio

Public$278M1052017San Mateo, CA, US

Board Member· Board

Leadership at Kronos Bio

Elena RidloffBoard Member

Otello StampacchiaBoard Member

Angela KoehlerCo-Founder

Arie BelldegrunBoard Member

David TanenBoard Member

Joshua KazamCo-Founder

Similar to Kronos Bio

Clovis OncologyBoulder, CO, USCancer Treatmentsest. 2009Clovis OncologyBoulder, CO, US · est. 2009

Clovis Oncology, a global biotech firm, specializes in developing and commercializing cancer treatments.

Public · $145M413

QronoPittsburgh, PA, USCancer Therapiesest. 2010QronoPittsburgh, PA, US · est. 2010

Qrono, Inc., a Pittsburgh-based biotech company, specializes in developing cancer tumor therapies.

BeOne MedicinesCambridge, MA, USCancer TreatmentsBeOne MedicinesCambridge, MA, US

BeiGene, a global biopharmaceutical firm, specializes in developing targeted and immuno-oncology cancer treatments.

Public · $6.8B10k

Revolution MedicinesRedwood City, CA, USOncology Therapiesest. 2014Revolution MedicinesRedwood City, CA, US · est. 2014

US-based Revolution Medicines, Inc. discovers novel oncology therapies targeting elusive growth pathways globally.

Public · $1.1B246

Morphic Therapeutic

Morphic Therapeutic

Public$510.5M1022015Waltham, MA, US

Board Member· Board

Leadership at Morphic Therapeutic

Praveen TipirneniBoard Member

Susannah GrayBoard Member

Joseph P. SlatteryBoard Member

Timothy SpringerBoard Member

Martin EdwardsBoard Member

Amir NashatBoard Member

Similar to Morphic Therapeutic

Pliant TherapeuticsSouth San Francisco, CA, USTherapeuticsPliant TherapeuticsSouth San Francisco, CA, US

Pliant Therapeutics: A California-based biopharmaceutical company innovating therapies for fibrotic diseases.

Public · $694.9M124

MorphoceuticalsMarblehead, MA, USBiotechnologyest. 2020MorphoceuticalsMarblehead, MA, US · est. 2020

Morphoceuticals Inc.: Pioneering bioelectric solutions for limb regeneration in biotechnology.

Forward TherapeuticsPalm Beach Gardens, FL, USOral Therapiesest. 2022Forward TherapeuticsPalm Beach Gardens, FL, US · est. 2022

Forward Therapeutics: Innovating chronic inflammatory treatment through advanced oral immune therapies.

Series A · $50M2

VeraMorphMansfield, MA, USPharmaceuticalsest. 2017VeraMorphMansfield, MA, US · est. 2017

VeraMorph: Innovating polymer-based oral dosage technology in pharmaceuticals since 2017.

Angel · $225k2

Rezo Therapeutics

Rezo Therapeutics

Series A$78M30South San Francisco, CA, US

Board Member· Board

Leadership at Rezo Therapeutics

Nevan KroganCo-Founder

George ScangosBoard Member

Sourav BandyopadhyayCo-Founder

InCarda Therapeutics

InCarda Therapeutics

Series A$86.4M102009Newark, CA, US

Board Member· Board

Leadership at InCarda Therapeutics

George BickerstaffBoard Member

Adam FreundCo-Founder

Narsi RangachariCo-Founder

Robert LisickiCEO

Carlos SchulerCo-Founder

Alan ColowickBoard Member

Similar to InCarda Therapeutics

Cardeas PharmaSeattle, WA, USAntibiotics, Pharmaceuticalsest. 2010Cardeas PharmaSeattle, WA, US · est. 2010

Cardeas Pharma: Specializing in developing inhaled antibiotics for respiratory infections.

Series B · $80M30

BioCardiaSan Carlos, CA, USMedical Devices, Therapeuticsest. 1999BioCardiaSan Carlos, CA, US · est. 1999

BioCardia, a San Carlos-based medical firm, develops innovative regenerative therapies for critical cardiovascular diseases.

Public · $41.3M28

Respira TherapeuticsAlbuquerque, NM, USDrug Delivery, Inhalationest. 2010Respira TherapeuticsAlbuquerque, NM, US · est. 2010

Respira: A drug delivery tech company specializing in efficient dry powder inhaler technologies.

Series B · $5.1M9

Cardurion PharmaceuticalsBurlington, MA, USTherapeuticsest. 2017Cardurion PharmaceuticalsBurlington, MA, US · est. 2017

Boston-based biotech firm specializing in next-gen therapeutics for heart diseases.

Series B · $343.1M42

Norbert Bischofberger's Co-Investors

John C. MartinCo-invested · Kronos Bio Seed

Norbert Bischofberger's Similar Executives & Operators

Soemantri BrodjonegoroBoard Member · Bukalapak

Lau Eng BoonBoard Member · Bukalapak

Willix HalimCEO · Bukalapak

Jay Geoffrey WacherBoard Member · Bukalapak

WILL WEI CHENGBoard Member · DiDi

Dhirubhai H. AmbaniBoard Member · Reliance Retail

Mason YeoBoard Member · Kakao

JaeHong ChoiBoard Member · Kakao

People Similar to Norbert Bischofberger

George SiberBoard Member · Selecta Biosciences

Michael FischbachBoard Member · Revolution Medicines

Andreas PlückthunCo-Founder · MorphoSys

Daniel KraftBoard Member · Xprize

Lynn ZechiedrichBoard Member · Baylor College of Medicine

Craig LindsleyBoard Member · Vanderbilt University